BACK
|In Follow Up

Renoir

This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of RSVpreF in the prevention of LRTI-RSV in adults.

More Information

Capital Area Research LLC © Copyright 2023 All rights reserved.
875 Popular Church Rd. Suite 330 Camp Hill, PA - 717.963.8389